Epicast: Nonalcoholic Steatohepatitis – Epidemiology Forecast to 2022:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Epicast: Nonalcoholic Steatohepatitis – Epidemiology Forecast to 2022 Aug 4th 2013, 13:34, by jayshree Nonalcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of a fatty, inflamed, and damaged liver. It resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. NASH is becoming increasingly common with the alarming epidemic of obesity. As obesity is a major risk factor for other metabolic syndrome diseases, such as type 2 diabetes and dyslipidemia, the incorporation of weights from the age- and sex-specific prevalence of obesity in each of the 6MM adds granularity to the forecast analysis, which allowed GlobalData epidemiologists to provide a comprehensive forecast of … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110273. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/epicast-nonalcoholic-steatohepatitis-epidemiology-forecast-to-2022-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions